Your browser doesn't support javascript.
loading
Anticancer Properties of Hexosamine Analogs Designed to Attenuate Metabolic Flux through the Hexosamine Biosynthetic Pathway.
Saeui, Christopher T; Shah, Sagar R; Fernandez-Gil, Beatriz I; Zhang, Cissy; Agatemor, Christian; Dammen-Brower, Kris; Mathew, Mohit P; Buettner, Matthew; Gowda, Prateek; Khare, Pratik; Otamendi-Lopez, Andrea; Yang, Shuang; Zhang, Hui; Le, Anne; Quinoñes-Hinojosa, Alfredo; Yarema, Kevin J.
Affiliation
  • Saeui CT; Department of Biomedical Engineering and The Translational Tissue Engineering Center, The Johns Hopkins University and Johns Hopkins School of Medicine, Baltimore, Maryland 21231, United States.
  • Shah SR; Department of Biomedical Engineering and The Translational Tissue Engineering Center, The Johns Hopkins University and Johns Hopkins School of Medicine, Baltimore, Maryland 21231, United States.
  • Fernandez-Gil BI; Department of Neurosurgery, Mayo Clinic, Jacksonville, Florida 32224, United States.
  • Zhang C; Department of Oncology, Johns Hopkins School of Medicine, Baltimore, Maryland 21205, United States.
  • Agatemor C; Department of Chemical and Biomolecular Engineering, The Johns Hopkins University, Baltimore, Maryland 21205, United States.
  • Dammen-Brower K; Department of Biomedical Engineering and The Translational Tissue Engineering Center, The Johns Hopkins University and Johns Hopkins School of Medicine, Baltimore, Maryland 21231, United States.
  • Mathew MP; Department of Biomedical Engineering and The Translational Tissue Engineering Center, The Johns Hopkins University and Johns Hopkins School of Medicine, Baltimore, Maryland 21231, United States.
  • Buettner M; Department of Biomedical Engineering and The Translational Tissue Engineering Center, The Johns Hopkins University and Johns Hopkins School of Medicine, Baltimore, Maryland 21231, United States.
  • Gowda P; Department of Biomedical Engineering and The Translational Tissue Engineering Center, The Johns Hopkins University and Johns Hopkins School of Medicine, Baltimore, Maryland 21231, United States.
  • Khare P; Department of Biomedical Engineering and The Translational Tissue Engineering Center, The Johns Hopkins University and Johns Hopkins School of Medicine, Baltimore, Maryland 21231, United States.
  • Otamendi-Lopez A; Department of Oncology, Johns Hopkins School of Medicine, Baltimore, Maryland 21205, United States.
  • Yang S; Department of Chemical and Biomolecular Engineering, The Johns Hopkins University, Baltimore, Maryland 21205, United States.
  • Zhang H; Department of Neurosurgery, Mayo Clinic, Jacksonville, Florida 32224, United States.
  • Le A; Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland 21287, United States.
  • Quinoñes-Hinojosa A; Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland 21287, United States.
  • Yarema KJ; Department of Oncology, Johns Hopkins School of Medicine, Baltimore, Maryland 21205, United States.
ACS Chem Biol ; 18(1): 151-165, 2023 01 20.
Article in En | MEDLINE | ID: mdl-36626752
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pancreatic Neoplasms / Antineoplastic Agents Limits: Animals Language: En Journal: ACS Chem Biol Year: 2023 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pancreatic Neoplasms / Antineoplastic Agents Limits: Animals Language: En Journal: ACS Chem Biol Year: 2023 Type: Article Affiliation country: United States